D.E. Shaw & Co
CDLX icon

D.E. Shaw & Co’s Cardlytics CDLX Stock Holding History

D.E. Shaw & Co’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,020
Closed -$674K – 5218
2022
Q2 		$674K Buy
+3,020
New +$1.01M ﹤0.01% 3896
2021
Q2 		– Sell
-1,000
Closed -$1.1M – 4767
2021
Q1 		$1.1M Buy
1,000
+510
+104% +$673K ﹤0.01% 3041
2020
Q4 		$700K Hold
490
– – ﹤0.01% 3231
2020
Q3 		$346K Hold
490
– – ﹤0.01% 3376
2020
Q2 		$343K Buy
+490
New +$283K ﹤0.01% 3565

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

D.E. Shaw & Co's CDLX Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 2,621 shares — an estimated $30.1K sold.

D.E. Shaw & Co first reported a position in CDLX in Q4 2019 and held it in 25 quarters. The position peaked at $25.6M in Q4 2019. 59 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,621 Cardlytics shares in Q1 2026, an estimated $30.1K.
  • D.E. Shaw & Co first reported a position in Cardlytics in Q4 2019 and held it in 25 quarters.
  • D.E. Shaw & Co's Cardlytics position peaked at $25.6M in Q4 2019.
  • 59 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.